Historical record - last NADAC effective date: 5/29/2015
Product Information
MESTINON 60 MG/5 ML SYRUP is a brand product labeled by Bausch Health US LLC, priced at $1.9930 per ML under NDC 00187301220. Its NADAC has been published 134 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the pyridostigmine bromide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/5mL
Manufacturer
Bausch Health US LLCNDC
00187301220
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
5/29/2015
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA015193FDA Approved
Before 1982
TE Code
AA
On Market Since
1/25/1965
Pharmacological Classes
Price Statistics
The NADAC for MESTINON 60 MG/5 ML SYRUP has been published 134 times since Nov 28, 2013, and over the history we have for it it has risen 330.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9930 per ML |
|---|---|
| All-time high | $1.9930 (Jun 15, 2016) |
| All-time low | $0.4625 (Nov 28, 2013) |
| Median price | $1.5769 |
| Average price | $1.4095 |
| Largest weekly change | +30.0% (Oct 8, 2014) |
| Weeks tracked | 134 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+330.9%
Last surveyed Jun 15, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pyridostigmine bromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MESTINON 60 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for MESTINON 60 MG/5 ML SYRUP, manufactured by Bausch Health US LLC, is $1.9930 per ML (NDC 00187301220), effective Jun 15, 2016.
How has the price of MESTINON 60 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for MESTINON 60 MG/5 ML SYRUP has risen 330.9%. It has been tracked across 134 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MESTINON 60 MG/5 ML SYRUP?
Since Nov 28, 2013, the NADAC for MESTINON 60 MG/5 ML SYRUP has ranged from a low of $0.4625 (Nov 28, 2013) to a high of $1.9930 (Jun 15, 2016), with a median of $1.5769 per ML.
Are there cheaper alternatives to MESTINON 60 MG/5 ML SYRUP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PYRIDOSTIGMINE 60 MG/5 ML SOLN, is $0.5648 per ML — about 72% below MESTINON 60 MG/5 ML SYRUP.
Who manufactures MESTINON 60 MG/5 ML SYRUP?
MESTINON 60 MG/5 ML SYRUP (NDC 00187301220) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.